Morningstar1mon
Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint
Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, has released enrollment performance metrics from their participation ...
Hosted on MSN1mon
H.C. Wainwright maintains $190 target on Cybin Inc. shares
In other recent news, Cybin Inc. has announced significant developments in its clinical trials and operations. The neuropsychiatry company initiated a strategic partnership with Segal Trials for a ...
Yahoo Finance1mon
Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint
MIAMI LAKES, Fla., January 22, 2025--(BUSINESS WIRE)--Segal Trials, a privately held clinical research network specializing in acute schizophrenia and other psychiatric disorders, has released ...